37 associate director statistical programming jobs at 30 companies in United States
3w
Save
Mark Applied
Hide
3w
Associate Director, Statistical Programming
United States
$175k-$220k/yrOnsiteFull Time
PepGenNasdaq: PEPG: Clinical-stage biotechnology developing oligonucleotide therapies for severe neuromuscular and neurologic diseases.
8+ YOEBS/MS in a relevant field and 8+ years of pharmaceutical or biotechnology statistical programming experience. Expert SAS required; CDISC and regulatory submission knowledge required. CRO oversight experience required.
SAS, R, SDTM, ADaM, Tables, Listings, and Figures (TLFs), define.xml, Statistical Analysis Plan (SAP), Case Report Form (CRF)
Avenzo Therapeutics: Clinical-stage biotechnology developing next-generation oncology therapies for cancer patients.
6+ YOEHands-on SAS statistical programmer with CDISC experience to lead programming for clinical study protocols, oversee CRO programmers, deliver SDTM/ADaM datasets and TLFs, and ensure regulatory compliance (ICH/FDA/GCP).
Corcept TherapeuticsNasdaq Capital Market: CORT: Public biopharmaceutical developing and commercializing cortisol-modulating medicines for severe endocrine, cancer, metabolic, and neurologic disorders.
10+ YOE10+ years clinical trial statistical programming experience, deep SAS and CDISC SDTM/ADaM knowledge, Pinnacle 21 experience, submission readiness, MS preferred, strong communication and independent problem-solving skills.
SAS BASE, SAS MACRO, SAS STAT, SAS GRAPH, SAS ACCESS, CDISC SDTM, CDISC ADaM, Pinnacle 21, Spotfire, Tableau, RShiny
10+ YOE10+ years SAS programming experience in pharma/biotech/CRO, experience leading programming teams, CDISC (SDTM/ADaM) knowledge, proficiency in R and SAS, strong communication and organization.
Centessa PharmaceuticalsNASDAQ: CNTA: Lilly-owned clinical-stage biopharmaceutical developing orexin receptor 2 agonists for patients with sleep-wake disorders.
10+ YOEMaster's degree with 10+ years or bachelor's degree with 15+ years of SAS programming in pharmaceutical, biotech, or CRO settings; CDISC, SDTM, ADaM, regulatory, and leadership experience required.
Regeneron PharmaceuticalsNASDAQ: REGN: Biotechnology discovering and developing life-transforming medicines.
10+ YOEMaster's degree and 10+ years clinical programming experience; advanced SAS (Base, Stat, Macro, Graph); project and people management; therapeutic area and regulatory submission knowledge.
10+ YOE10+ years SAS programming experience in pharma/biotech/CRO, CDISC SDTM/ADaM expertise, leadership experience, proficiency with R, strong communication and regulatory submission experience. Bachelor's required; Master's preferred.
Zenas BioPharmaNasdaq Global Select Market: ZBIO: Public clinical-stage biopharmaceutical developing and commercializing immunology therapies for patients with autoimmune diseases.
7+ YOEMaster's in Biostatistics/CS with 7+ years or Bachelor's with 9+ years; strong SAS and CDISC (SDTM/ADaM) knowledge; regulatory filing and ISS/ISE experience; CRO/vendor management and excellent communication.
Avalo TherapeuticsNasdaq Capital Market: AVTX: Public clinical-stage biotechnology developing IL-1β-based medicines for people with immune-mediated inflammatory diseases.
7+ YOE7+ years statistical programming experience (Sr Manager) or 9+ years (Associate Director) in biotech/pharma/CRO; advanced SAS proficiency, CDISC (SDTM/ADaM/Define.xml) expertise, experience with regulatory submissions, vendor/CRO oversight, and leadership/mentorship experience.
Harvard T.H. Chan School of Public Health: Nonprofit Harvard public health school educating leaders, conducting research, and developing solutions to improve population health and equity.
7+ YOERequires 7+ years of post-secondary education or relevant experience, supervisory experience, and extensive SAS expertise. Preferred: 7+ years of statistical programming, clinical research experience, and SAS, R, Bash, Linux, and Python skills.
SystImmune: US clinical-stage biopharmaceutical developing bispecific, multispecific antibodies and antibody-drug conjugates for cancer patients.
10+ YOE5+ MgmtBachelor's or master's degree in a numerate discipline; 10+ years in biostatistics or statistical programming in pharma/biotech; 5+ years leading teams; English and Chinese fluency; regulatory and CDISC expertise.
Rapport TherapeuticsNasdaq Global Market: RAPP: Public clinical-stage biopharmaceutical developing precision small-molecule medicines for neurological and psychiatric disorders.
8+ YOEBachelor's or master's degree in a quantitative or life science field; 8–10 years of biotech, pharmaceutical, or CRO statistical programming experience; expert SAS and CDISC expertise; team leadership and regulatory submission experience.
SAS, SAS Base, SAS Macro, SAS STAT, SAS GRAPH, CDISC, SDTM, ADaM, R, Python, eCTD, define.xml, cSDRG, ADRG
Associate Director, Statistical Programming - R Implementation
Basking Ridge, New Jersey, United States
$171k-$257k/yrOnsiteFull Time
Daiichi SankyoTokyo Stock Exchange: 4568: Global pharmaceutical advancing breakthrough therapies in oncology and medicine.
10+ YOEBachelor's degree in science or technology and 10+ years' experience, or master's degree and 7+ years. Requires R, SAS, CDISC SDTM/ADaM, clinical trials, statistics, and database expertise.
MBX BiosciencesNasdaq Global Select Market: MBX: Clinical-stage biopharmaceutical developing precision peptide therapies for patients with endocrine and metabolic disorders.
8+ YOERequires 8+ years of biotech or pharmaceutical statistical programming experience, advanced SAS proficiency, CDISC standards expertise, and CRO oversight; R and Python experience preferred.
SAS, Base SAS, SAS/Stat, SAS/Graph, SAS macros, ODS, R, Python, CDISC, SDTM, ADaM, define.xml, eSub, eCTD, SAPs, Case Report Forms (CRFs), Table, Listing, and Figure (TLF)
Neurocrine BiosciencesNasdaq Global Select Market: NBIX: Develops treatments for neurological, psychiatric, endocrine, and immunological disorders.
6+ YOERequires BS/BA with 10+ years, master's with 8+ years, or PhD with 6+ years in biopharmaceutical or CRO statistical programming, advanced SAS, managerial experience, CDISC knowledge, and leadership skills.
SAS, Microsoft Word, Microsoft Excel, Microsoft PowerPoint, SDTM, ADaM, CDISC
Dyne TherapeuticsNasdaq Global Select Market: DYN: Clinical-stage biotechnology developing targeted therapies for people with genetically driven neuromuscular diseases.
10+ YOEBachelor's required (advanced degree preferred). Minimum 10 years statistical programming in pharma/biotech. Advanced SAS required; experience with R/Python, CDISC SDTM/ADaM, eCTD, regulatory submissions, vendor oversight, and leadership experience.
Travere TherapeuticsNasdaq: TVTX: Public biopharmaceutical developing and commercializing therapies for people with rare kidney and metabolic diseases.
8+ YOE3+ Mgmt8+ years clinical research experience with SAS programming for phases I-IV, 3+ years lead programming experience, CDISC/SDTM/ADaM expertise, submission support, vendor management, and strong SAS and MS Office skills.
Regeneron PharmaceuticalsNASDAQ: REGN: Biotechnology discovering and developing life-transforming medicines.
10+ YOEMaster's degree, 10+ years clinical programming experience, advanced SAS skills, project and people management experience, therapeutic area expertise, ability to lead global teams and oversee outsourced providers.
Principal / Associate Director, Statistical Programming
Conshohocken, Pennsylvania, United States
$180k-$219k/yrOnsiteFull Time
Madrigal PharmaceuticalsNASDAQ Global Market: MDGL: Public biopharmaceutical developing and commercializing treatments for MASH patients with serious liver disease.
10+ YOEBachelor's in a quantitative or life science field (Master's preferred), 10+ years pharmaceutical/biotech statistical programming with regulatory submission experience, strong SAS (macros) skills, R preferred, CDISC SDTM/ADaM expertise, and CRO oversight experience.